Cargando…
Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children
BACKGROUND: Recurrent pericarditis (RP) is a complication (15–30%) of acute pericarditis with an unknown etiology. Treatment regimen consists of a combination of non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine, with the addition of corticosteroids in resistant or intolerant cases. In t...
Autores principales: | Signa, Sara, D’Alessandro, Matteo, Consolini, Rita, Miniaci, Angela, Bustaffa, Marta, Longo, Chiara, Tosca, Maria A., Bizzi, Martina, Caorsi, Roberta, Mendonça, Leonardo Oliveira, Pession, Andrea, Ravelli, Angelo, Gattorno, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298800/ https://www.ncbi.nlm.nih.gov/pubmed/32546242 http://dx.doi.org/10.1186/s12969-020-00438-5 |
Ejemplares similares
-
Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases
por: Papa, Riccardo, et al.
Publicado: (2020) -
Chronic active EBV infection mimicking periodic fever syndromes: a new challenge for the paediatrician
por: Caorsi, Roberta, et al.
Publicado: (2014) -
Anti-interleukin-1 agents for pericarditis: a primer for cardiologists( )
por: Imazio, Massimo, et al.
Publicado: (2021) -
An Update on Familial Mediterranean Fever
por: Lancieri, Maddalena, et al.
Publicado: (2023) -
Incidence rate of MIS‐C in paediatrics: A good reason to vaccinate children against SARS‐CoV‐2
por: Castagnola, Elio, et al.
Publicado: (2021)